Premium
Randomised controlled trial comparing the efficacy of same‐day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol
Author(s) -
Guest J,
Chien PFW,
Thomson MAR,
Kosseim ML
Publication year - 2007
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2006.01179.x
Subject(s) - misoprostol , medicine , mifepristone , medical abortion , obstetrics , pregnancy , gestation , regimen , abortion , products of conception , gynecology , randomized controlled trial , early pregnancy loss , surgery , genetics , biology
Objective To determine the efficacy of oral mifepristone followed by vaginal misoprostol 6 hours later compared with the standard 36‐ to 48‐hour regimen for medical termination of pregnancy. Design Single centre, two arm, parallel, open randomised controlled trial. Setting Medical termination service at a teaching hospital. Sample Four hundred and fifty women undergoing medical termination of pregnancy at up to 63 days of gestation. Methods Eligible women were randomised to receive mifepristone 200 mg orally followed by vaginal misoprostol 800 micrograms either 6 hours ( n = 225) or 36–48 hours ( n = 225) later. All participants were invited to attend for a follow‐up pelvic ultrasound scan within 7 days following the misoprostol administration. For those women in whom products of conception remained at the follow‐up ultrasound scan, expectant management ensued with weekly follow‐up ultrasound scans until the termination was complete. They could elect to undergo an evacuation of uterus at any stage following the scan. Those women with a nonviable gestation sac at the follow‐up scan were offered a further dose of vaginal misoprostol 800 micrograms or suction termination of pregnancy. Women with a continuing pregnancy were managed with surgical termination. Main outcome measure Successful medical abortion defined as no requirement for medical or surgical intervention beyond the initial dose of misoprostol. Results One hundred and sixty‐five women (79%) in the 6‐hour group and 197 women (92%) in the 36‐ to 48‐hour group had a successful termination at first follow‐up ultrasound or presumed on the basis of other considerations (those not seen for ultrasound but deemed successful by negative pregnancy test, products passed on ward or long‐term assessment of notes). Twenty‐two women (10%) in the 6‐hour regimen required up to three further ultrasound scans after 7 days following the mifepristone administration in order to ensure that the termination process was complete. None of these women required a suction evacuation of uterus. In the 36‐ to 48‐hour regimen, ten (5%) women had up to two further ultrasound scans to confirm a complete termination without the need for a surgical evacuation of uterus. Therefore, the overall successful termination rate in the 6‐hour regimen was 89% (187/210) compared with 96% (207/215) in the 36‐ to 48‐hour regimen (relative risk = 0.92, 95% CI 0.84–0.98). Repeat administration of misoprostol or surgical treatment was required in 23 women (11%) in the 6‐hour group and 8 women (4%) in the 36‐ to 48‐hour group. A viable pregnancy was found in five women (2%) in the 6‐hour group and in three women (1%) in the 36‐ to 48‐hour group. Conclusions Oral mifepristone 200 mg followed by vaginal misoprostol 800 micrograms after 6 hours is not as effective at achieving a complete abortion compared with the 36‐ to 48‐hour protocol.